Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430) - Lyss,A.P.; Herndon,J.E.; Lynch,T.J. (Clin Lung Cancer, 2002)